id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-290490-u3mkfvxw	Armstrong-James, Darius	Confronting and mitigating the risk of COVID-19 Associated Pulmonary Aspergillosis (CAPA)	2020-07-23		.txt	text/plain	2294	103	37	Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and physicians treating patients with COVID-19-related lung disease need to actively consider these fungal co-infections. Influenza-associated pulmonary aspergillosis (IAPA) presents a known risk to critically unwell patients with influenza (12) (13) (14) and the clinical course of COVID-19 shows many features that are shared with severe influenza infection. Although the host risk factors and clinical characteristics of CAPA are not yet understood, those individuals fulfilling the criteria for proven or probable aspergillosis (13, 14) should then be treated according to current guidelines (31, 32) . Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients Beta-Dglucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study Invasive pulmonary aspergillosis complicating COVID-19 in the ICU -A case report	./cache/cord-290490-u3mkfvxw.txt	./txt/cord-290490-u3mkfvxw.txt